Loading clinical trials...
Loading clinical trials...
Gonorrhoea Resistance Assessment by Nucleic Acid Detection: A Program Evaluation
Conditions
Interventions
Resistance guided treatment for gonorrhoea infection
Locations
1
Australia
University of Queensland
Brisbane, Queensland, Australia
Start Date
April 26, 2022
Primary Completion Date
July 30, 2023
Completion Date
July 30, 2024
Last Updated
November 28, 2022
NCT06815536
NCT07246837
NCT07093450
NCT06743204
NCT06951438
NCT06188442
Lead Sponsor
The University of Queensland
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions